Synergy CHC Corp. priced an underwritten public offering of 1,750,000 shares of common stock at $2.50 per share for $4.375 million in gross proceeds. The offering is expected to close on August 27, 2025, and net proceeds will be used for working capital. Bancroft Capital, LLC is the sole book-running manager for the offering. The Company will issue warrants to the underwriters to purchase up to 52,500 shares of common stock. A registration statement on Form S-1 was filed with the SEC on August 15, 2025. Synergy CHC Corp. develops and markets consumer health and wellness products, including FOCUSfactor® and Flat Tummy®.

For more information, contact Gateway Group at 949.574.3860 or [email protected].

Read more at GlobeNewswire: Synergy CHC Corp. Announces Pricing of $4.375 Million